When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia

PVI, PeerView Institute for Medical Education
PVI, PeerView Institute for Medical EducationPVI, PeerView Institute for Medical Education
••
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia
1 de 58

When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia

••
Baixar para ler offline
Saúde e medicina

Chair, R. Scott Wright, MD, discusses hyperlipidemia in this CME activity titled “When Statins Strike Out: Using PCSK9-Targeting Strategies to Achieve Lipid Goals and Reduce Cardiovascular Risks in Patients With Hyperlipidemia.” For the full presentation, downloadable Practice Aids, and complete CME information, and to apply for credit, please visit us at https://bit.ly/3Xn62gu. CME credit will be available until August 24, 2024.

PVI, PeerView Institute for Medical Education
PVI, PeerView Institute for Medical EducationPVI, PeerView Institute for Medical Education

Recomendados

Cases in the Community: Optimizing Treatment and Considering Weight Managemen...Cases in the Community: Optimizing Treatment and Considering Weight Managemen...
Cases in the Community: Optimizing Treatment and Considering Weight Managemen...PVI, PeerView Institute for Medical Education
6 visualizações•51 slides
Making the Most of Advances in Amyotrophic Lateral Sclerosis: Strategies to I...Making the Most of Advances in Amyotrophic Lateral Sclerosis: Strategies to I...
Making the Most of Advances in Amyotrophic Lateral Sclerosis: Strategies to I...PVI, PeerView Institute for Medical Education
5 visualizações•35 slides
Honing Diagnostic and Management Skills: The Role of the Pediatrician in the ...Honing Diagnostic and Management Skills: The Role of the Pediatrician in the ...
Honing Diagnostic and Management Skills: The Role of the Pediatrician in the ...PVI, PeerView Institute for Medical Education
8 visualizações•6 slides
Facing the Challenges of EoE Head On: A Game Plan for Diagnosis and Integrati...Facing the Challenges of EoE Head On: A Game Plan for Diagnosis and Integrati...
Facing the Challenges of EoE Head On: A Game Plan for Diagnosis and Integrati...PVI, PeerView Institute for Medical Education
6 visualizações•33 slides
Finding the Right Pathway in Psoriasis: New Insights and Applications for TYK...Finding the Right Pathway in Psoriasis: New Insights and Applications for TYK...
Finding the Right Pathway in Psoriasis: New Insights and Applications for TYK...PVI, PeerView Institute for Medical Education
6 visualizações•63 slides
Revolutionizing Solid Tumor Treatment, Unleashing the Potential of Antibody–D...Revolutionizing Solid Tumor Treatment, Unleashing the Potential of Antibody–D...
Revolutionizing Solid Tumor Treatment, Unleashing the Potential of Antibody–D...PVI, PeerView Institute for Medical Education
5 visualizações•98 slides

Mais conteúdo relacionado

Mais de PVI, PeerView Institute for Medical Education

Mais de PVI, PeerView Institute for Medical Education(20)

From Early Recognition to Age- and Stage-Appropriate Care: Navigating a New E...From Early Recognition to Age- and Stage-Appropriate Care: Navigating a New E...
From Early Recognition to Age- and Stage-Appropriate Care: Navigating a New E...
PVI, PeerView Institute for Medical Education•4 visualizações
From Early Recognition to Age- and Stage-Appropriate Care: Navigating a New E...From Early Recognition to Age- and Stage-Appropriate Care: Navigating a New E...
From Early Recognition to Age- and Stage-Appropriate Care: Navigating a New E...
PVI, PeerView Institute for Medical Education•4 visualizações
Clearing the Way for Pediatric Patients of All Races With Moderate to Severe ...Clearing the Way for Pediatric Patients of All Races With Moderate to Severe ...
Clearing the Way for Pediatric Patients of All Races With Moderate to Severe ...
PVI, PeerView Institute for Medical Education•4 visualizações
Building a Better Bridge: Providing Continuous SMA Care From Adolescence Thro...Building a Better Bridge: Providing Continuous SMA Care From Adolescence Thro...
Building a Better Bridge: Providing Continuous SMA Care From Adolescence Thro...
PVI, PeerView Institute for Medical Education•5 visualizações
Diagnosing and Managing Axial Spondyloarthritis: The Role of the Primary Care...Diagnosing and Managing Axial Spondyloarthritis: The Role of the Primary Care...
Diagnosing and Managing Axial Spondyloarthritis: The Role of the Primary Care...
PVI, PeerView Institute for Medical Education•4 visualizações
Optimizing the Care of Patients With SCLC in the Community Setting: How to Ma...Optimizing the Care of Patients With SCLC in the Community Setting: How to Ma...
Optimizing the Care of Patients With SCLC in the Community Setting: How to Ma...
PVI, PeerView Institute for Medical Education•35 visualizações
Realizing the Potential of Rapid-Acting Treatments for Depression: Key Clinic...Realizing the Potential of Rapid-Acting Treatments for Depression: Key Clinic...
Realizing the Potential of Rapid-Acting Treatments for Depression: Key Clinic...
PVI, PeerView Institute for Medical Education•9 visualizações
Following the Evolution of Cardiac Myosin Inhibition: Remodeling Clinical Wor...Following the Evolution of Cardiac Myosin Inhibition: Remodeling Clinical Wor...
Following the Evolution of Cardiac Myosin Inhibition: Remodeling Clinical Wor...
PVI, PeerView Institute for Medical Education•15 visualizações
Choosing Wisely, Achieving Control With BTKi in CLL: Perspectives on Safety-...Choosing Wisely, Achieving Control With BTKi in CLL: Perspectives on Safety-...
Choosing Wisely, Achieving Control With BTKi in CLL: Perspectives on Safety-...
PVI, PeerView Institute for Medical Education•5 visualizações
Reversal of Misfortune: Practical Insights for Managing Uncontrolled FXa-Inhi...Reversal of Misfortune: Practical Insights for Managing Uncontrolled FXa-Inhi...
Reversal of Misfortune: Practical Insights for Managing Uncontrolled FXa-Inhi...
PVI, PeerView Institute for Medical Education•4 visualizações
FcRn Modulation as a Targeted Approach to Myasthenia Gravis Management: From ...FcRn Modulation as a Targeted Approach to Myasthenia Gravis Management: From ...
FcRn Modulation as a Targeted Approach to Myasthenia Gravis Management: From ...
PVI, PeerView Institute for Medical Education•5 visualizações
Chronic Kidney Disease in Patients With Type 2 Diabetes: The Impetus for Earl...Chronic Kidney Disease in Patients With Type 2 Diabetes: The Impetus for Earl...
Chronic Kidney Disease in Patients With Type 2 Diabetes: The Impetus for Earl...
PVI, PeerView Institute for Medical Education•7 visualizações
Living With Eosinophilic Esophagitis: Recognizing the Burden on Patients and ...Living With Eosinophilic Esophagitis: Recognizing the Burden on Patients and ...
Living With Eosinophilic Esophagitis: Recognizing the Burden on Patients and ...
PVI, PeerView Institute for Medical Education•4 visualizações
Tumor Treating Fields as an Innovative Modality of Cancer Therapy: From CNS t...Tumor Treating Fields as an Innovative Modality of Cancer Therapy: From CNS t...
Tumor Treating Fields as an Innovative Modality of Cancer Therapy: From CNS t...
PVI, PeerView Institute for Medical Education•4 visualizações
Expert Perspectives on Improving Early Recognition and Treatment of COPD With...Expert Perspectives on Improving Early Recognition and Treatment of COPD With...
Expert Perspectives on Improving Early Recognition and Treatment of COPD With...
PVI, PeerView Institute for Medical Education•4 visualizações
Command and Control MDS: New Science in MDS Management and Implications for V...Command and Control MDS: New Science in MDS Management and Implications for V...
Command and Control MDS: New Science in MDS Management and Implications for V...
PVI, PeerView Institute for Medical Education•7 visualizações
Leveraging Early GLP-1 RA Initiation to Reduce Risks and Improve Long-Term Ou...Leveraging Early GLP-1 RA Initiation to Reduce Risks and Improve Long-Term Ou...
Leveraging Early GLP-1 RA Initiation to Reduce Risks and Improve Long-Term Ou...
PVI, PeerView Institute for Medical Education•8 visualizações
Removing Obstructions for Improved HCM Care: Leveling Up Diagnosis and Manage...Removing Obstructions for Improved HCM Care: Leveling Up Diagnosis and Manage...
Removing Obstructions for Improved HCM Care: Leveling Up Diagnosis and Manage...
PVI, PeerView Institute for Medical Education•4 visualizações
Now Is the Time to Overcome Therapeutic Inertia in T2D to Achieve Personalize...Now Is the Time to Overcome Therapeutic Inertia in T2D to Achieve Personalize...
Now Is the Time to Overcome Therapeutic Inertia in T2D to Achieve Personalize...
PVI, PeerView Institute for Medical Education•9 visualizações
Defying the Odds With Innovation in CLL: Perspectives on Personalized Care, M...Defying the Odds With Innovation in CLL: Perspectives on Personalized Care, M...
Defying the Odds With Innovation in CLL: Perspectives on Personalized Care, M...
PVI, PeerView Institute for Medical Education•6 visualizações